Advocates Win 'Exceptional' Boost for Alzheimer's Research

Posted: Feb. 28, 2012

Researcher Rudolph Tanzi is quoted extensively in Science Magazine's recent article concerning the Obama administration's decision to increase funding for Alzheimer's disease research. The decision, announced last week, includes an increase of $80 million for research, as well as the reprogramming of $50 million from the National Institutes of Health's annual budget. As Tanzi stated, "it's persistence" from the lobbyists that finally has made this disease a national priority.

Cure Alzheimer’s Fund’s Response to NAPA

Posted: Feb. 24, 2012

On Feb. 22, 2012, the Department of Health and Human Services issued the first “Draft National Plan to Address Alzheimer’s Disease." The plan is mandated by the National Alzheimer’s Project Act (NAPA), bipartisan legislation signed into law in January 2011 by President Obama. NAPA’s goals are to:

Create and maintain an integrated national plan to overcome Alzheimer’s disease which will:

Bexarotene, a new wonder drug for Alzheimer’s?

Posted: Feb. 10, 2012

Dr. Gary Landreth and colleagues at Case Western Reserve published a paper online in Science Express yesterday that received much attention because of the rather stunning results it reports in stopping and even reversing “a broad range of Abeta-induced deficits."

Cure Alzheimer’s Research Consortium Members Rudy Tanzi and Sam Gandy Say Exercise is Key

Posted: Feb. 9, 2012

Exercise and stimulation of the brain may help ward off Alzheimer's disease, according to Dr. Tanzi and Dr. Gandy, both Cure Alzheimer's Fund Research Consortium members who were recently quoted in an article in the AARP Bulletin.

ABC News Quotes Cure Alzheimer's Fund President and CEO Tim Armour on Obama Administration Announcement

Posted: Feb. 8, 2012

Upon the announcement that the Obama administration will put $156 million toward Alzheimer’s research within the next two years, ABC news covered the story and quoted Cure Alzheimer’s President and CEO Tim Armour:

“Alzheimer’s threatens to bankrupt our health care system, affect the quality of care provided to patients and mature into one of the worst health care crises our nation has ever seen,” Armour said.

Obama Administration Makes Alzheimer’s Research Top Priority

Posted: Feb. 7, 2012

Findings from Cure Alzheimer’s Fund Help Drive the Alzheimer’s Initiative

“Alzheimer’s takes a devastating toll on millions of Americans,” said Kathleen Sebelius, secretary of Health and Human Services. “It’s a very important health issue. The time for bold action is right now.”

Third Annual Running 4 Answers Road Race

Posted: Feb. 6, 2012

On Saturday morning, April 28, co-founders Carolyn Mastrangelo and Barbara Geiger will hold the third annual Running 4 Answers fundraiser on the tree-lined streets of historic Roseland and Essex Fells, N.J. This four-mile race/two-mile fun run/walk brings families together to honor loved ones whom they have lost to Alzheimer’s and helps raise money toward finding a cure. The event is sanctioned by USATrack & Field–New Jersey.

New Studies Affirm Tau's Infectious Spread

Posted: Feb. 2, 2012

Cure Alzheimer’s Fund a Longtime Supporter of Tau Research

by Rudy Tanzi

The New York Times has a front-page story on the spreading of tau pathology from neuron to neuron, citing papers from the laboratories of Dr. Brad Hyman of Massachusetts General Hospital and Dr. Karen Duff of Columbia University. Cure Alzheimer's Fund has been supporting key research along these lines over the past two years, and is playing a major role going forward.

Dr. Tanzi Featured Expert on Alzheimer’s Genome Project™ on

Posted: Jan. 26, 2012

Dr. Rudolph Tanzi, chairman of the Cure Alzheimer’s Fund Research Consortium, is now featured on the Discovery Channel-based website Tanzi provides answers to numerous questions posed by Curiosity with the intention of informing the public about Alzheimer’s disease and the Alzheimer’s Genome Project™.

To see some of the answers to today’s most pressing questions about Alzheimer’s, click here.